2-Arylmethylaminomethyl-5,6-dihydroxychromone derivatives with selective anti-HCV activity

  • Hye Ri Park
  • , Kwang Su Park
  • , Youhoon Chong

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

Anti-HCV activity of aryl diketoacid (ADK) has been characterized by its two pharmacophoric elements, α,β-diketo acid moiety and substituted aryl ring. In this study, as a part of our ongoing efforts to discover a novel anti-HCV compound mimicking the ADK scaffold, we designed 2- arylmethylaminomethyl-5,6-dihydroxychromone derivatives of which the dihydroxychromone moiety as well as the arylmethylaminomethyl substituent (R-PhCH 2NHCH 2-) were anticipated in exact match with the pharmacophore model of the ADK. The dihydroxychromone derivatives (3a-3u), thus prepared, showed biological activity in a substituent-dependent fashion, thereby leading to selective anti-HCV effect (EC 50 = 2.0-14.0 μM, CC 50 >100 μM) with the substituent groups such as Cl, Br, I, and Me specifically at the 3-position of the aromatic ring.

Original languageEnglish
Pages (from-to)3202-3205
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume21
Issue number11
DOIs
StatePublished - 1 Jun 2011
Externally publishedYes

Keywords

  • 2-Arylmethylaminomethyl-5,6-dihydroxychromone
  • ADK (aryl diketoacid)
  • Bioisostere
  • Hepatitis C virus (HCV)

Fingerprint

Dive into the research topics of '2-Arylmethylaminomethyl-5,6-dihydroxychromone derivatives with selective anti-HCV activity'. Together they form a unique fingerprint.

Cite this